Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study.

[1]  D. Rubin,et al.  Reducing Bias in Observational Studies Using Subclassification on the Propensity Score , 1984 .

[2]  E. J. Brown,et al.  The effect of digoxin on mortality and morbidity in patients with heart failure. , 1997, The New England journal of medicine.

[3]  A. Levey,et al.  A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.

[4]  M. Mcclellan,et al.  Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function. , 2000, Archives of internal medicine.

[5]  P D Cleary,et al.  Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores. , 2001, Journal of clinical epidemiology.

[6]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  R. Sims,et al.  Survival Benefits of Angiotensin‐Converting Enzyme Inhibitors in Older Heart Failure Patients with Perceived Contraindications , 2002, Journal of the American Geriatrics Society.

[8]  J. Collins,et al.  Determination of vital status at the end of the DIG trial. , 2003, Controlled clinical trials.

[9]  Harlan M Krumholz,et al.  The association of left ventricular ejection fraction, mortality, and cause of death in stable outpatients with heart failure. , 2003, Journal of the American College of Cardiology.

[10]  K. Freedland,et al.  Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction. , 2003, American heart journal.

[11]  Harlan M Krumholz,et al.  Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial. , 2004, Journal of the American Society of Nephrology : JASN.

[12]  T. Larson,et al.  Using Serum Creatinine To Estimate Glomerular Filtration Rate: Accuracy in Good Health and in Chronic Kidney Disease , 2004, Annals of Internal Medicine.

[13]  D. Rubin.  Using Propensity Scores to Help Design Observational Studies: Application to the Tobacco Litigation , 2001, Health Services and Outcomes Research Methodology.

[14]  K. Swedberg,et al.  Heart failure with preserved left ventricular systolic function; epidemiology, clinical characteristics, and prognosis. , 2004, Journal of the American College of Cardiology.

[15]  P. Armstrong,et al.  Renal Insufficiency and Heart Failure: Prognostic and Therapeutic Implications From a Prospective Cohort Study , 2004, Circulation.

[16]  P. Rothwell.  Subgroup analysis in randomised controlled trials: importance, indications, and interpretation , 2005, The Lancet.

[17]  M. Rich,et al.  Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. , 2006, European heart journal.

[18]  M. Rich,et al.  Effects of angiotensin-converting enzyme inhibitors in systolic heart failure patients with chronic kidney disease: a propensity score analysis. , 2006, Journal of Cardiac Failure.

[19]  M. Gheorghiade,et al.  Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. , 2006, European heart journal.

[20]  J. Fleg,et al.  Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis. , 2006, American heart journal.